Notice of Correction to NIDDK Specific Interests in PAR-16-027 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance (SB1)"

Notice Number: NOT-DK-16-004

Key Dates
Release Date: December 4, 2015

Related Announcements
PAR-16-027

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is correcting the language in the Funding Opportunity Description of PAR-16-027 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance (SB1)" as follows:

Part 2. Section I. Funding Opportunity Description

Interests of Specific Institutes/Centers

The FOA reads:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The NIDDK will accept CRP applications from NIDDK Phase II funded institutions, provided they are within the NIDDK mission. NIDDK also participates in the Commercialization Readiness Pilot (CRP) Program: Technical Assistance (PAR-16-026) so applicants interested in only requesting technical assistance should apply through that funding opportunity.

The FOA is modified to read:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIDDK is interested in CRP applications from DK Phase II or Phase IIB SBIR-funded applicants in the General Topic Areas listed above, provided they are within the NIDDK mission.

Applications for research involving human subjects can be submitted in response to this FOA, but NIDDK may decline funding of any application that includes human subjects for programmatic or administrative reasons. SBIR applicants considering projects involving human subjects are strongly encouraged to contact Scientific/Research staff.

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Christine Densmore, M.S.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-496-8714
Email: [email protected]